LC-MS/MS analysis of Chlorates in Milk and Whey Powder using the Agilent 6470 QQQ

Similar documents
A Robustness Study for the Agilent 6470 LC-MS/MS Mass Spectrometer

Authors. Abstract. Forensic Toxicology. Irina Dioumaeva, John M. Hughes Agilent Technologies, Inc.

Vitamin D Metabolite Analysis in Biological Samples Using Agilent Captiva EMR Lipid

Analysis of anti-epileptic drugs in human serum using an Agilent Ultivo LC/TQ

Reduced Ion Suppression and Improved LC/MS Sensitivity with Agilent Bond Elut Plexa

DETERMINATION OF CANNABINOIDS, THC AND THC-COOH, IN ORAL FLUID USING AN AGILENT 6490 TRIPLE QUADRUPOLE LC/MS

Author. Introduction. Small Molecule Pharmaceuticals & Generics

Application Note. Author. Abstract. Introduction. Food Safety

Efficient Quantitative Analysis of THC and Metabolites in Human Plasma Using Agilent Captiva EMR Lipid and LC-MS/MS

Quantitative Analysis of Underivatized Amino Acids in Plant Matrix by Hydrophilic Interaction Chromatography (HILIC) with LC/MS Detection

LC/MS/MS of Trichothecenes and Zearalenone in Wheat Using Different Sample Prep Methods

Mycotoxin Analysis in Peanut Butter Using Captiva EMR Lipid Cleanup and LC/MS/MS

Detection, Confirmation, and Quantification of Chloramphenicol in Honey, Shrimp and Chicken Using the Agilent 6410 LC/MS Triple Quadrupole

Analyze Barbiturates in Urine with Agilent 6430 LC/MS/MS and Poroshell 120 EC-C18

LC/MS/MS Separation of Cholesterol and Related Sterols in Plasma on an Agilent InfinityLab Poroshell 120 EC C18 Column

Quantitative Analysis of Opiates in Urine Using RRHT LC/MS/MS. Application. Authors. Introduction. Abstract. Forensics

Extended Mass Range Triple Quadrupole for Routine Analysis of High Mass-to-charge Peptide Ions

Determination of β2-agonists in Pork Using Agilent SampliQ SCX Solid-Phase Extraction Cartridges and Liquid Chromatography-Tandem Mass Spectrometry

Determination of Amantadine Residues in Chicken by LCMS-8040

Quantification of lovastatin in human plasma by LC/ESI/MS/MS using the Agilent 6410 Triple Quadrupole LC/MS system

A FORENSIC TOXICOLOGY METHOD FOR THE DETERMINATION OF DESOMORPHINE, HEROIN, METHADONE, BUPRENORPHINE AND METABOLITES IN URINE USING LC/MS QQQ

SPE-LC-MS/MS Method for the Determination of Nicotine, Cotinine, and Trans-3-hydroxycotinine in Urine

Amphetamines, Phentermine, and Designer Stimulant Quantitation Using an Agilent 6430 LC/MS/MS

Determination of Pharmaceutical Residues in Bovine Milk via LC MS/MS Following Solid Phase Extraction

Supporting Information

Analysis of Cholesterol-Lowering Drugs (Statins) Using Dried Matrix Spot Technology

Fast quantitative Forensic Analysis of THC and its Metabolites in Biological Samples using Captiva EMR- Lipid and LC/MSMS

Mycotoxin Analysis in Infant Formula Using Captiva EMR Lipid Cleanup and LC/MS/MS

Ultrafast Analysis of Benzodiazepines in Urine by the Agilent RapidFire High-Throughput Triple Quadrupole Mass Spectrometry System

Sunil Kulkarni Product Specialist Agilent Technologies

Application Note. Abstract. Authors. Pharmaceutical

Mass-Based Purification of Natural Product Impurities Using an Agilent 1260 Infinity II Preparative LC/MSD System

Analysis of mycotoxins in food matrices using the Agilent Ultivo Triple Quadrupole LC/MS

Analysis of Rosuvastatin in Dried Blood Spot and Plasma Using ACQUITY UPLC with 2D Technology

LCMS Vitamin D3 Method development

Development of a Bioanalytical Method for Quantification of Amyloid Beta Peptides in Cerebrospinal Fluid

Extraction of a Comprehensive Steroid Panel from Human Serum Using ISOLUTE. SLE+ Prior to LC/MS-MS Analysis

Quantitative Determination of Drugs of Abuse in Human Plasma and Serum by LC/MS/MS Using Agilent Captiva EMR Lipid Cleanup

Performance of an ultra low elution volume 96-well plate

Vitamin D3 and related compounds by ESI and APCI

A RAPID AND SENSITIVE ANALYSIS METHOD OF SUDAN RED I, II, III & IV IN TOMATO SAUCE USING ULTRA PERFORMANCE LC MS/MS

Extraction of 25-hydroxy Vitamin D from Serum Using ISOLUTE. PLD+ Prior to LC-MS/MS Analysis

The Raptor HILIC-Si Column

Agilent 6470 Triple Quadrupole LC/MS System and EMR-Lipid. The Combination for Confident Pesticide Quantitation. Christoph Mueller

Fully Automated Online Sample Preparation AND Quantification of Amiodarone from Whole Blood using CLAM-LC-MS/MS

LC/MS Method for Comprehensive Analysis of Plasma Lipids

LC-MS/MS Method for the Determination of Tenofovir from Plasma

Multiclass Mycotoxin Analysis in Cheese Using Agilent Captiva EMR Lipid Cleanup and LC/MS/MS

Qualitative and quantitative determination of cannabinoid profiles and potency in CBD hemp oil using LC/UV and Mass Selective Detection

Analysis of Acrylamide in French Fries using Agilent Bond Elut QuEChERS AOAC kit and LC/MS/MS

Determination of Patulin in Apple Juice Using SPE and UHPLC-MS/MS Analysis

Analysis of Testosterone, Androstenedione, and Dehydroepiandrosterone Sulfate in Serum for Clinical Research

Determination of Eight Estrogens in Milk by UHPLC and the Agilent 6495 Triple Quadrupole Mass Spectrometer

Authors. Abstract. Introduction. Environmental

Dr. Erin E. Chambers Waters Corporation. Presented by Dr. Diego Rodriguez Cabaleiro Waters Europe Waters Corporation 1

Robust extraction, separation, and quantitation of structural isomer steroids from human plasma by SPE-UHPLC-MS/MS

Rapid Analysis of Water-Soluble Vitamins in Infant Formula by Standard-Addition

A Novel Solution for Vitamin K₁ and K₂ Analysis in Human Plasma by LC-MS/MS

Determination of 6-Chloropicolinic Acid (6-CPA) in Crops by Liquid Chromatography with Tandem Mass Spectrometry Detection. EPL-BAS Method No.

Modified QuEChERS for HILIC LC/MS/MS Analysis of Nicotine and Its Metabolites in Fish

Extraction of Multiple Mycotoxins From Nuts Using ISOLUTE Myco prior to LC-MS/MS Analysis

Transferring a Method for Analysis of DNPH-Derivatized Aldehydes and Ketones from HPLC to UHPLC

Meeting Challenging Requirements for the Quantitation of Regulated Growth Promoters Dexamethasone and Betamethasone in Liver and Milk

Comprehensive Study of SLE as a Sample. Preparation Tool for Bioanalysis

What You Can t See Can Hurt You. How MS/MS Specificity Can Bite Your Backside

Fat-Soluble Vitamins Analysis on an Agilent ZORBAX Eclipse PAH Polymeric C18 Bonded Column

Highly sensitive simultaneous quantitative analysis of estrone and equilin from plasma using LC/MS/MS

Improved Isolation and Analysis of Mycotoxins from Cereals, Beer and Wine

Extraction of Multiple Mycotoxins From Grain Using ISOLUTE Myco prior to LC-MS/MS Analysis

Analysis of Vitamins Using an SFC/UHPLC Hybrid System with a Triple Quadrupole LC/MS for Quantification

Simultaneous Analysis of Intact Human Insulin and Five Analogs in Human Plasma Using μelution SPE and a CORTECS UPLC Column

Separation of Polyphenols by Comprehensive 2D-LC and Molecular Formula Determination by Coupling to Accurate Mass Measurement

Agilent 6460 LC-QQQ Highly Sensitive and Robust Analysis for Lipophilic Marine Toxins in Shellfish

Breaking the Sensitivity Barrier in Triple Quad LC/MS Performance

Cannabinoid Quantitation Using an Agilent 6430 LC/MS/MS

Analysis of Per- and Polyfluoroalkyl Substances (PFASs) in Biological Fluid Using a Novel Lipid Removing Sorbent and LC-MS/MS

Sample Preparation Techniques for Biological Matrices: Finding the right balance to achieve optimal results

Determination of 44 Pesticides in Foodstuffs by LC/MS/MS Application

A Novel Platform of On-line Sample Pre-treatment and LC/MS/MS Analysis for Screening and Quantitation of Illicit Drugs in Urine

LC/MS/MS of Buprenorphine and Norbuprenorphine in Whole Blood Using Agilent Bond Elut Plexa PCX and an Agilent Poroshell 120 Column

Determination of Amphetamine and Derivatives in Urine

Cannabinoid Profiling and Quantitation in Hemp Extracts using the Agilent 1290 Infinity II/6230B LC/TOF system

Analytical Method for 2, 4, 5-T (Targeted to Agricultural, Animal and Fishery Products)

Determination of Multi-Residue Tetracyclines and their Metabolites in Milk by High Performance Liquid Chromatography - Tandem Mass Spectrometry

Fully automated sensitive determination of immunosuppressant drugs in whole blood, using high quality internal standardization

Determination of Ractopamine and Clenbuterol in Beef Samples

Filtration Approaches to Sample Preparation and Cleanup. Golnar Javadi Application Engineer Sample Preparation Products

Rapid and Accurate LC-MS/MS Analysis of Nicotine and Related Compounds in Urine Using Raptor Biphenyl LC Columns and MS-Friendly Mobile Phases

Protein Precipitation for Biological Fluid Samples Using Agilent Captiva EMR Lipid 96-Well Plates

Fig. 1: Chemical structure of arachidonic acid COOH CH 3

Extraction of Aflatoxin M1 From Infant Formula Using ISOLUTE Myco SPE Columns prior to LC-MS/MS Analysis

The New 6495 Triple Quadrupole LC/MS

PerkinElmer talks at spring TCJJP Meeting Wednesday, Mar. 14, 2012

The Investigation of Factors Contributing to Immunosuppressant Drugs Response Variability in LC-MS/MS Analysis

2D-LC as an Automated Desalting Tool for MSD Analysis

Determination of Aflatoxins in Food by LC/MS/MS. Application. Authors. Abstract. Experimental. Introduction. Food Safety

New Solvent Grade Targeted for Trace Analysis by UHPLC-MS

Sample Concentration and Analysis of Human Hormones in Drinking Water

Transcription:

LC-MS/MS analysis of Chlorates in Milk and Whey Powder using the Agilent 6470 QQQ Anthony Sullivan, LC/MS Product Specialist Melanie Mülek and Christoph Müller LC-MS Applications Specialists Hewlett-Packard-Str. 8 76337 Waldbronn Germany

Use/Occurence of Chlorate Non-selective herbicide (banned since 2010) Disinfection byproduct (Chlorine dioxide, hypochlorite disinfectants, but also in caustic soda) By-product of chlorination of drinking water (wash and irrigation water) Page 2

Why are Chlorate Levels Regulated? Negative health effects Competes with iodide for transport to the thyroid, reversibly inhibits the absorption of iodide At high doses Cause health hazards in sensitive groups such as children, pregnant women or people with thyroid disfunction Can cause damage to red blood cells Irreversible formation of methemoglobin from hemoglobin after cell lysis Page 3

Where is Chlorate Regulated? Drinking Water No maximum levels for chlorate in drinking water have been set in the European Union WHO has established a guideline level for chlorate in drinking water of 0.7 mg/l Food No specific maximum residue levels established for chlorate under Regulation (EC) No 396/2005 Therefore, a default MRL of 0.01 mg/kg is applicable Page 4

Relevance to Dairy Processing Industry Chlorinated process water Cleaning of processing equipment Amount of chlorate depending on type of chlorination (chlorine, chlorine dioxide, hypochlorite) Chlorination often required to kill microorganisms, that could cause greater negative health effects than chlorate! Page 5

Aim of method development for chlorate analysis in milk and whey powder To balance presence of chlorate by (inevitable) cleaning/disinfection and remain within regulated MRL, frequent analysis of chlorate levels is required Improve sensitivity and speed compared to established methods (QuPPe porous graphite column, mixed mode column) Evaluate sample preparation options Determine performance of Agilent 6470 QQQ in chlorate analysis Page 6

Method development steps Optimize mass spectrometer for chlorate detection Explore alternative to established methods good retention but faster, good peak shape and reproducibility Test different sample preparation techniques for successful clean-up, simplicity Page 7

LC Development and Optimization Columns Porous Graphite Mixed mode (RP + ion exchange) Poroshell PFP 2.1 x 100 mm; 2.7 µm Poroshell PFP Better peak intensity Best retention excellent RT reproducibility Eluents Formic vs acetic acid Increasing acetic acid concentration: 0/0.01/0.1/1 % Methanol/Acetonitrile 1000000 Influence of the amount of acetic acid in water as mobile phase (A) Chlorate 83>67 [Peak area] 800000 600000 400000 200000 0 0% 0.01% 0.1% 1% Page 8

Optimized Method 1290 Infinity II UHPLC Stationary Phase: Poroshell PFP, 2.1 x 100 mm, 2.7 µm Temperature: 40 C Mobile Phase A: 1 % HAC in Water Mobile Phase B: MeOH Flow: 0.4 ml/min Gradient: 0 min 0.1 % B 2.50 min 60 % B 2.51 min 100 % B 4 min 100 % B 4.01 min 5 % B 6 min 5 % B Stop Time: 6 min Injection: 1 µl Needle Wash: 10 s Flush Port; Methanol:Water:Formic acid (50:50:0.1; v/v) Page 9

Optimized Method 6470 QQQ Electrospray Ionization with Agilent Jet Stream Ion Source Drying Gas: 150 C, 8 L/min Sheath Gas: 400 C, 11 L/min Nebulizer: 45 psi Capillary: 2000 V Nozzle: 0 V MS-Parameter ESI Polarity: negative Scan Type: MRM Transitions: 2 Cycle Time: 207 ms ΔEMV: +200 V Optimized source parameters in solvent, milk and whey powder samples Optimized transitions Compound Name Precursor MS1 Res Product MS 2 Res Dwell FV CE CAV Polarity Chlorate 85 Unit 69 Wide 100 130 26 4 Negative Chlorate 83 Unit 67 Wide 100 140 26 5 Negative Page 10

6470 Performance: Serial Dilution in Solvent - Sensitivity / Linearity / Repeatability - Sensitivity: LLOQ 0.05 ppb S/N (peak-to-peak; noise region: 1.6 1.8 min; n= 3): 9.2 Quantifier: Qualifier: Page 11

6470 Performance: Serial Dilution in Solvent - Sensitivity / Linearity / Repeatability - Serial dilution of chlorate in water (11 levels): 0.05 1000 ng/ml Page 12

6470 Performance: Serial Dilution in Solvent - Sensitivity / Linearity / Repeatability - Page 13

Sample preparation - Method Development Approach - Post-extraction method (1,2) : set of three samples per technique Standards spiked into blank matrix Blank sample matrix (no analytes) Recovery: Sample preparation RE [%] = Response extracted spiked sample Response post extracted spiked sample x 100 Sample matrix (with analytes) Standards spiked into extracted matrix Matrix effects: ME [%] = Response post extracted spiked sample 1 x 100 Response standard solution Process efficiency: PE [%] = Response extracted spiked sample Response standard solution x 100 Extracted SPIKED samples POSTextracted SPIKED samples Standard solution (contains analytes) (1) B.K. Matuszewski, M.L. Constanzer, and C.M. Chavez-Eng, Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Analytical Chemistry 75 (2003) 3019-3030. (2) E. Chambers et al., Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses. J Chromatogr B Analyt Technol Biomed Life Sci 852 (2007) 22-34. Page 14

Chlorate in milk - Sample preparation - Sample volume: 0.5 ml milk (homogenized pasteurized low-fat milk; 1.5% fat) + 10 ppb chlorate spiked PPT: protein precipitation; SPE: solid phase extraction Sample Preparation Process PPT 1 Addition of MeOH cold (1:2) PPT 2 Addition of MeOH cold (1:3) PPT 3 Addition of 1% HAC in MeOH cold (1:3) PPT 4 Addition of 1% HAC in MeOH cold (1:1) PPT 5 Addition of 1% HAC in MeOH cold (1:2) PPT 6 Addition of ACN cold (1:2) PPT 7 Addition of ACN cold (1:1) PPT 8 Addition of 1% HAC in ACN cold (1:3) PPT 9 Addition of 1% FA in ACN cold (1:3) PPT 10 Addition of 1% HAC in ACN cold (1:2) SPE Bond Elut Plexa 45 40 35 30 Process efficiency Chlorate [%] Recovery Chlorate 0[%] 25 20 15 10 5 0 40 35 30 25 20 15 10 5 PPT 1 PPT 2 PPT 3 PPT 4 PPT 5 PPT 6 PPT 7 PPT 8 PPT 9 PPT 10 SPE 1 Plexa Set 1: Extracted spiked samples containing chlorate (10 ppb) Set 2: Post-extracted spiked samples; chlorate (10 ppb) was added to the extracted matrix blank Set 3: Standard solution; chlorate (10 ppb) in 100% water PPT 1 PPT 2 PPT 3 PPT 4 PPT 5 PPT 6 PPT 7 PPT 8 PPT 9 PPT 10 SPE 1 Plexa Page 15

Chlorate in milk - Sensitivity x10 Blank [Chlorate] 2 83.0 -> 67.0 Final Conc.=0.012 S/N=1.1 85.0 -> 69.0 S/N=0.9 5.2 5 Water 4.8 4.6 4.4 Blank Milk [Chlorate] 83.0 -> 67.0 Final Conc.=1.138 S/N=139.1 85.0 -> 69.0 S/N=78.7 Milk (unspiked) S/N* 139 1 ppb [Chlorate] 83.0 -> 67.0 Final Conc.=2.015 S/N=223.6 85.0 -> 69.0 S/N=112.3 Milk (1 ppb spike) S/N* 223 2.5 ppb [Chlorate] 83.0 -> 67.0 Final Conc.=3.695 S/N=431.6 85.0 -> 69.0 S/N=152.1 Milk (2.5 ppb spike) S/N* 431 4.2 4 3.8 3.6 3.4 3.2 3 Quantification of chlorate in milk by standard addition after precipitation 2.8 2.6 2.4 0.99 ng/ml 2.2 2 1.8 1.6 1.4 1.2 1 0.8 0.6 1.6 1.7 1.8 1.9 2 2.1 2.2 2.3 2.4 1.6 1.7 1.8 1.9 2 2.1 2.2 2.3 2.4 1.6 1.7 1.8 1.9 2 2.1 2.2 2.3 2.4 1.6 1.7 1.8 1.9 2 2.1 2.2 2.3 2.4 (about 1 ppb chlorate in blank milk prevents direct determination of LLOQ, estimated LLOQ based on S/N at 1 ppb spike level with consideration of contribution from chlorate in blank milk is 0.1 ppb) *(peak-to-peak; noise region: 1.6 1.8 min): Page 16

Sample Dilution The excellent instrument sensitivity allows dilution of the sample, resulting in reduced matrix effect, which means more accurate quantification Dilution factor considered in calculated concentration (Expected concentration 10 ng/ml) x10 3 1.5 1.45 1.4 1.35 1.3 PPT 3 spiked [Chlorate] 83.0 -> 67.0 Final Conc.=3.01 S/N=1651.1 85.0 -> 69.0 S/N=494.8 1.55 Undiluted Conc. 3.01 ng/ml PPT 3 spiked Dil 1_10 [Chlorate] 83.0 -> 67.0 Final Conc.=5.04 S/N=220.8 85.0 -> 69.0 S/N=72.6 10x diluted Conc. 5.04 ng/ml PPT 3 spiked Dil 1_20 [Chlorate] 83.0 -> 67.0 Final Conc.=5.52 S/N=72.9 85.0 -> 69.0 S/N=23.2 20x diluted Conc. 5.52 ng/ml PPT 3 spiked Dil 1_50 [Chlorate] 83.0 -> 67.0 Final Conc.=5.58 S/N=37.8 85.0 -> 69.0 S/N=10.5 50x diluted Conc. 5.58 ng/ml PPT 3 spiked Dil 1_100 [Chlorate] 83.0 -> 67.0 Final Conc.=5.26 S/N=18.1 85.0 -> 69.0 S/N=5.8 100x diluted Conc. 5.26 ng/ml 1.25 1.2 1.15 1.1 1.05 1 0.95 0.9 0.85 0.8 0.75 0.7 0.65 Lower concentration found in undiluted sample due to ion suppression Already 10x dilution sufficient to remove matrix effects 0.6 0.55 0.5 0.45 0.4 0.35 0.3 0.25 0.2 0.15 0.1 0.05 1.6 1.7 1.8 1.9 2 2.1 2.2 2.3 2.4 1.6 1.7 1.8 1.9 2 2.1 2.2 2.3 2.4 1.6 1.7 1.8 1.9 2 2.1 2.2 2.3 2.4 1.6 1.7 1.8 1.9 2 2.1 2.2 2.3 2.4 1.6 1.7 1.8 1.9 2 2.1 2.2 2.3 2.4 Page 17

Chlorate in milk - Repeatability Page 18

Chlorate in whey powder - Sample preparation - Sample volume: 0.5 g whey powder 100 ng/g chlorate spiked (0% casein, 1% fat, 12% protein, 1% ash, high lactose) Approach: 0.5 g whey powder + 4.4 ml water + 0.1 ml spike solution chlorate in water 0.5 ml for sample clean-up Page 19

Chlorate in whey powder Sample Preparation by Precipitation Sensitivity: LLOQ could not be established directly in matrix, due to high chlorate concentration in available whey powder x10 4 2.3 2.2 2.1 Whey Blank [Chlorate] 83.0 -> 67.0 Final Conc.=332.003 S/N=219.9 2.4 85.0 -> 69.0 S/N=157.7 Whey Powder S/N* 220 75 ppb [Chlorate] 83.0 -> 67.0 Final Conc.=69.092 S/N=255.2 85.0 -> 69.0 S/N=196.2 75 ppb spike S/N* 255 100 ppb [Chlorate] 83.0 -> 67.0 Final Conc.=105.459 S/N=233.7 85.0 -> 69.0 S/N=172.0 100 ppb spike S/N* 233 250 ppb [Chlorate] 83.0 -> 67.0 Final Conc.=275.833 S/N=355.0 85.0 -> 69.0 S/N=276.7 250 ppb spike S/N* 355 500 ppb [Chlorate] 83.0 -> 67.0 Final Conc.=487.999 S/N=480.7 85.0 -> 69.0 S/N=359.1 500 ppb spike S/N* 480 2 1.9 1.8 1.7 1.6 1.5 1.4 1.3 1.2 Quantification of chlorate in whey powder by standard addition after precipitation 1.1 1 0.9 332 ng/g 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.1 1.7 1.8 1.9 2 2.1 2.2 2.3 2.4 2.5 1.7 1.8 1.9 2 2.1 2.2 2.3 2.4 2.5 1.7 1.8 1.9 2 2.1 2.2 2.3 2.4 2.5 1.7 1.8 1.9 2 2.1 2.2 2.3 2.4 2.5 1.7 1.8 1.9 2 2.1 2.2 2.3 2.4 2.5 *(peak-to-peak; noise region: 1.6 1.8 min): Page 20

Chlorate in whey powder Sample Preparation by Solid Phase Extraction In contrast to milk, whey powder could also be cleaned up by solid phase extraction, retaining matrix on the cartridge and leaving chlorate in the load/wash liquid Whey powder: cleared by SPE Milk: passes through milky Several SPE cartridges tested Best recovery of chlorate was found with Bond Elut Nexus Polymeric sorbent with no pre-conditioning required Improved simplicity! Using standard addition and Bond Elut Nexus SPE, chlorate in whey powder could be quantified as 349 ng/g * Quant. by external calibration delivers significantly lower results at 130 ng/g with PPT and 253 ng/g with standard addition Page 21

18 O 3 -Chlorate as Internal Standard No isotopically labeled internal standard was used in this study in order to understand the true performance of the UHPLC-QQQ method, and it was shown that with the more rapid LC method, standard addition could be a more economical alternative to 18 O 3 -Chlorate Page 22

Summary Excellent sensitivity of new UHPLC-QQQ method Allows for significant sample dilution to reduce matrix effects Short runtime (6 min) Facilitates accurate quantification through standard addition instead of use of expensive 18 O 3 -labeled internal standard. Compatible with different sample preparation techniques for both milk and whey powder Page 23